Related references
Note: Only part of the references are listed.Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia
Robert W. Buchanan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2020)
An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis
N. Cakici et al.
PSYCHOLOGICAL MEDICINE (2019)
The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial
Mark Weiser et al.
SCHIZOPHRENIA RESEARCH (2019)
Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2x2 double-blind, randomized, placebo-controlled, phase IIA clinical trial
Jonathan B. Savitz et al.
TRANSLATIONAL PSYCHIATRY (2018)
Meta-assessment of bias in science
Daniele Fanelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
Iris E. Sommer et al.
SCHIZOPHRENIA BULLETIN (2014)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Convergent Findings for Abnormalities of the NF-κB Signaling Pathway in Schizophrenia
Panos Roussos et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials
Masahiro Nitta et al.
SCHIZOPHRENIA BULLETIN (2013)
被撤回的出版物: Anti-Inflammatory Effects of Chronic Aspirin on Brain Arachidonic Acid Metabolites (Retracted article. See vol. 40, pg. 1094, 2015)
Mireille Basselin et al.
NEUROCHEMICAL RESEARCH (2011)
Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders: Results From a Randomized, Double-Blind, Placebo-Controlled Trial
Wijnand Laan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
Norbert Mueller et al.
SCHIZOPHRENIA RESEARCH (2010)
Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)
Richard S. E. Keefe et al.
SCHIZOPHRENIA RESEARCH (2008)
Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
Shahin Akhondzadeh et al.
SCHIZOPHRENIA RESEARCH (2007)
Celecoxib augmentation of continuously Ill patients with schizophrenia
MH Rapaport et al.
BIOLOGICAL PSYCHIATRY (2005)
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress
S Prabakaran et al.
MOLECULAR PSYCHIATRY (2004)
Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia
N Müller et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia
I Maurer et al.
SCHIZOPHRENIA RESEARCH (2001)
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis
S Derry et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Share Paper
